Study to Compare Laser Assisted New Attachment Procedure (LANAP) to Traditional Treatments of Chronic Periodontitis (LANAP)

September 15, 2015 updated by: Institute for Advanced Laser Dentistry

A Multi-Center Single Blind Study of the Laser Assisted New Attachment Procedure Compared to Scaling and Root Planing Alone, Modified Widman Flap Surgery, and Coronal Debridement Alone in the Treatment of Chronic Periodontitis

The purpose of this study is to compare the Laser Assisted New Attachment Procedure (LANAP protocol) using the Free-running (FR) Pulsed Neodimium: Yttrium aluminium garnet (Nd:YAG) laser to Scaling and Root Planing (SRP) alone, Modified Widman Flap (MFF) surgery, and Coronal Debridement (CD) alone with respect to periodontal clinical attachment level gain.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This multi-center study of the Laser Assisted New Attachment Procedure (LANAP protocol) using the FR Pulsed Nd:YAG laser compared to Scaling and Root Planing alone, Modified Widman Flap (MWF) surgery, and Coronal Debridement (CD) alone will utilize a single-blind, four-quadrant split-mouth design with MWF as the positive control, CD as a weak positive control and SRP as the standard treatment control. The study will be conducted at three (3) to five (5) investigational centers. Subjects will receive the Laser Assisted New Attachment Procedure (LANAP protocol) using the pulsed FR Nd:YAG laser, Scaling and Root Planing alone, Modified Widman Flap surgery, and Coronal Debridement alone each in one quadrant of their mouth at Baseline. Treatment modalities are randomly assigned to quadrants at the time of treatment.

Efficacy evaluations, including clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP) will be performed at Baseline, month 6, and month 12 using a Florida Electronic Probe. Radiographs will be taken at Screening/Baseline and at month 6 and month 12.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80045
        • University of Colorado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

23 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subjects will have chronic adult periodontitis as characterized by all four quadrants of the mouth.
  2. Subjects will be 25-75 years of age.
  3. Subjects will be able to follow verbal and/or written instructions, perform Oral Hygiene according to the protocol, and return to the center for specified study visits.
  4. Subjects must have had no subgingival scaling instrumentation including scaling and root planing, regular periodontal maintenance procedures or any subgingival cleaning < 12 (twelve) months prior to Baseline examination.
  5. Subjects must have had no history of periodontal surgical procedures of any type prior to Baseline examination.
  6. Subjects must be non-smokers of any type or former smokers (>6 (six) months stopped), and not using or taking any nicotine product.
  7. Subjects will have clinical and/or radiographic evidence of subgingival calculus in each quadrant.
  8. Subjects have no more than one missing tooth per quadrant, excluding 3rd molars.
  9. Subjects will be able to sign the informed consent form.

Exclusion Criteria:

  1. Subject receiving subgingival scaling instrumentation including scaling and root planing, regular periodontal maintenance procedures or any subgingival cleaning less than twelve (12) months prior to Baseline examination.
  2. Subjects receiving periodontal surgery of any type prior to Baseline examination.
  3. Subjects with dental implants.
  4. Subjects with a compromised heart condition, history of rheumatic fever, or joint replacement requiring prophylaxis.
  5. Subjects having taken systemic cancer therapy and/or radiation therapy at any time
  6. Subjects with clinically significant acute or concurrent illness
  7. Subjects with clinically significant chronic illness.
  8. Subjects with a disease of the connective tissue.
  9. Subjects taking medications which are likely to cause gingival hyperplasia, within ONE MONTH prior to Baseline examination
  10. Subjects taking antimicrobials within ONE MONTH prior to Baseline examination
  11. Subjects taking non-steroidal anti-inflammatory drugs at a therapeutic dose within the TWO WEEKS prior to Baseline examination.
  12. Subjects taking steroids of any kind within ONE MONTH prior to baseline examination.
  13. Subjects taking continuous low doses of tetracycline within THREE MONTHS prior to Baseline examination
  14. Subjects taking an investigational drug within TWO MONTHS prior to Baseline examination
  15. Subjects taking or having taken bisphosphonates of any kind for any reason.
  16. Female, nonsterile subjects who are pregnant or lactating.
  17. Subjects who, in the investigator's opinion, would not comply with the study procedures.
  18. Smokers of any type or former smokers and subjects that take or use any nicotine product.
  19. Excessive alcohol intake.
  20. No current restorative or endodontic treatment needs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: LANAP Quadrant
Treated with LANAP
Laser Assisted New Attachment Procedure (LANAP protocol) using the FR Pulsed Nd:YAG laser
Other Names:
  • Periolase MVP 7
No Intervention: Modified Widman Flap
Quadrant treated with Modified Widman Flap surgery
No Intervention: Scaling and Root Planing
Quadrant treated with scaling and root planing alone
No Intervention: Coronal Debridement
Quadrant treated with coronal debridement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gain in Clinical Attachment Level of Periodontal Tissues
Time Frame: Baseline, 6, 12 months
Periodontitis causes loss of attachment of the tooth root to the surrounding bone. Change in Clinical Attachment Level (CAL) estimates the number of mm's of reattachment gained as a result of the treatment.
Baseline, 6, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Probing Depth (PD)
Time Frame: Baseline, 6, 12 months
Positive numbers indicate average decrease in probing depth (improvement).
Baseline, 6, 12 months
Change in Bleeding on Probing (BOP)
Time Frame: Baseline, 6, 12 months

Percent of pockets within a quadrant that changed from baseline to 6 or 12 months. Negative numbers are a decrease in bleeding on probing which represents clinical improvement.

Each quadrant within the patient represents one of four treatments, the unit of analysis. Pockets are replications within treatments and vary in number among quadrants.

Baseline, 6, 12 months
Change in Gingival Index
Time Frame: Baseline, 6, 12 months
The gingival index is a 0-4 unit scale that the examiner uses to estimate the amount of edema and erythema at 2 locations (lingual and buccal) for every tooth in the quadrant. Zero (0) represents no redness and swelling and four (4) represents severe redness and swelling. Negative numbers are a decrease in in examiner estimate of erythema and edema and represent an improvement in clinical outcome.
Baseline, 6, 12 months
Discomfort
Time Frame: 1-7 days
Subjects recorded in a diary discomfort on a 10 point visual analog scale daily for the week following treatment. Subjects provided an estimate for each of the four treated quadrants. Zero (0) represents no pain or discomfort and ten (10) represents severe pain and/or discomfort. For each subject discomfort scores on each day from Day 1 to Day 7 were summed. Medians and ranges for each treatment are recorded. The total score could range from 0 to 70.
1-7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Raymund A Yukna, DMD, MS, University of Colorado Scholl of Dentistry
  • Principal Investigator: Henry Greenwell, DMD. MSD, University of Louisville, School of Dentistry
  • Principal Investigator: Mark Reynolds, DDS, PhD, University of Maryland, School of Dentistry
  • Principal Investigator: James Finley, DMD, Finley Periodontics
  • Principal Investigator: Thomas McCawley, DDS, McCawly & DeTure

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

January 13, 2011

First Submitted That Met QC Criteria

January 21, 2011

First Posted (Estimate)

January 24, 2011

Study Record Updates

Last Update Posted (Estimate)

October 14, 2015

Last Update Submitted That Met QC Criteria

September 15, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • MDT MC 06-001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Periodontitis

Clinical Trials on LANAP

3
Subscribe